March 02, 2018

Snippet roundup: Mylan lines up Botox biosimilar but Vernalis sinks

January 10, 2018

M&A: 2017 proves snooze-worthy on the acquisition front

Pharma and biotech takeover activity slumps to a five-year low in 2017.

September 14, 2017

Therapy focus – Atopic dermatitis competition Jaks up

July 20, 2017

Looking for value in the deal sweet spot

April 25, 2017

Fresenius shows biotech how to get the deals done

April 11, 2017

First-quarter deal making shows glimmers of growth

2017 deal making opens with a bang, though transaction volume remains low.

December 19, 2016

Patience rewards Ionis and Ziarco

September 23, 2015

After Turing, the industry’s biggest price gougers

September 03, 2015

UCB far from rehabilitated, despite divestment and study success